An effective Obesity drug has now been approved for teens

Published On 2022-12-30 12:11 GMT | Update On 2022-12-30 12:11 GMT

The Food and Drug Administration (FDA) has recently expanded the eligibility of Novo Nordisk's Wegovy, a medication indicated for the treatment of obesity in children as young as 12.

Wegovy is a prescription medicine indicated for adults with obesity (BMI ≥30) or overweight (excess weight) (BMI ≥27) who also have weight-related medical problems to help them lose weight and keep it off used with a reduced-calorie meal plan and increased physical activity.

Check out the Medical Dialogues official site for more health news:

https://medicaldialogues.in/

Full View

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Roshni Dhar

Roshni Dhar, a Mass com graduate with a soft corner for health happenings, joined Medical Dialogues as a news anchor in 2021. Inspired by her mother who is a gynaecologist, she likes to keep herself and the world updated on the occurring in the medical field. She covers various aspects of health news for MDTV at Medical Dialogues. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

An effective Obesity drug has now been approved for teens

Similar News